Login / Signup

Impact of Low-Dose rATG Prior to Matched Sibling Donor Hematopoietic Stem Cell Transplantation for Hematologic Malignancies: Reduced Risk of Chronic Graft-versus-Host Disease and Improved Survival Outcomes.

Zheng-Yang SongHan-Yun RenYu-Jun DongYuan LiYue YinYu Hua SunQian WangWei-Lin XuWei LiuJin-Ping OuZe-Yin Liang
Published in: Cancer management and research (2020)
Low-dose rATG used in MSD-HSCT as part of the conditioning regimen results in a reduced incidence of cGVHD and improves survival outcomes.
Keyphrases
  • low dose
  • high dose
  • acute myeloid leukemia
  • risk factors
  • hematopoietic stem cell